KK
COLL icon

KLP Kapitalforvaltning’s Collegium Pharmaceutical COLL Stock Holding History

KLP Kapitalforvaltning’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Hold
6,700
– – ﹤0.01% 1827
2026
Q1 		$222K Hold
6,700
– – ﹤0.01% 1782
2025
Q4 		$310K Sell
6,700
-14,400
-68% -$602K ﹤0.01% 1660
2025
Q3 		$738K Buy
21,100
+1,500
+8% +$52.1K ﹤0.01% 1203
2025
Q2 		$580K Sell
19,600
-10,600
-35% -$302K ﹤0.01% 1290
2025
Q1 		$901K Buy
30,200
+4,500
+18% +$138K ﹤0.01% 982
2024
Q4 		$736K Buy
+25,700
New +$850K ﹤0.01% 1134

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

KLP Kapitalforvaltning's COLL Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 6,700 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #1827.

KLP Kapitalforvaltning first reported a position in COLL in Q4 2024 and has held it in 7 quarters since. The position peaked at $901K in Q1 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • KLP Kapitalforvaltning held 6,700 shares of Collegium Pharmaceutical worth $243K as of Q2 2026.
  • KLP Kapitalforvaltning left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1827 holding.
  • KLP Kapitalforvaltning first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Collegium Pharmaceutical position peaked at $901K in Q1 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.